Henry Schein's (HSIC) activist investor Ananym Capital Management is asking the company to revamp its board, consider divesting its medical distribution business, reduce expenses, and replace Chief Executive Stanley Bergman, Reuters reported Monday, citing sources close to the matter.
The firm told the company executives that selling the medical distribution segment could boost the share price by roughly 20%, while cost reductions could drive earnings per share growth of nearly 35%, the sources reportedly said.
Ananym Capital projects over $2.5 billion in proceeds from the divestment that can be used for repurchasing its undervalued shares, the sources added.
Neither Henry Schein nor Ananym Capital immediately responded to MT Newswires' requests for comment.
Shares of the Henry Schein were up 6.2% in recent trading.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 73.06, Change: +4.30, Percent Change: +6.25
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.